$13.76
0.01000.07%
At Close: -
$13.72
-0.04-0.29%
After Hours: 7:52 PM EDT
15 minutes delayed
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
05/09/2024 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $355.00M | — | $333.87M | Get Alert |
05/09/2024 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $410.00M | — | $389.87M | Get Alert |
02/28/2024 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $330.00M | — | $315.30M | Get Alert |
02/28/2024 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $380.00M | — | — | Get Alert |
01/08/2024 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $256.00M | $258.00M | $252.79M | Get Alert |
01/08/2024 | ADMA | ADMA Biologics | Q4 | 2023 | — | — | — | $72.00M | $74.00M | $68.49M | Get Alert |
11/08/2023 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $335.00M | — | — | Get Alert |
11/08/2023 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $290.00M | — | $278.40M | Get Alert |
11/08/2023 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $250.00M | — | $243.06M | Get Alert |
08/09/2023 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $275.00M | — | $262.00M | Get Alert |
08/09/2023 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $240.00M | — | $226.03M | Get Alert |
08/09/2023 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $325.00M | — | — | Get Alert |
05/10/2023 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $220.00M | — | $212.36M | Get Alert |
05/10/2023 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $250.00M | — | $258.84M | Get Alert |
05/10/2023 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $300.00M | — | — | Get Alert |
03/23/2023 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $300.00M | — | — | Get Alert |
03/23/2023 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $250.00M | — | — | Get Alert |
03/23/2023 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $210.00M | — | $202.75M | Get Alert |
01/17/2023 | ADMA | ADMA Biologics | FY | 2023 | — | — | — | $210.00M | — | $197.45M | Get Alert |
01/17/2023 | ADMA | ADMA Biologics | FY | 2022 | — | — | — | $153.00M | $154.00M | $148.95M | Get Alert |
01/17/2023 | ADMA | ADMA Biologics | Q4 | 2022 | — | — | — | $49.00M | $50.00M | $43.75M | Get Alert |
12/06/2022 | ADMA | ADMA Biologics | FY | 2022 | — | — | — | $152.00M | $154.00M | $145.86M | Get Alert |
12/06/2022 | ADMA | ADMA Biologics | Q4 | 2022 | — | — | — | $48.00M | $50.00M | $40.66M | Get Alert |
11/09/2022 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $250.00M | — | — | Get Alert |
11/09/2022 | ADMA | ADMA Biologics | FY | 2022 | — | — | — | $145.00M | $145.00M | $134.39M | Get Alert |
08/10/2022 | ADMA | ADMA Biologics | FY | 2022 | — | — | — | $130.00M | — | $131.92M | Get Alert |
08/10/2022 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $250.00M | — | — | Get Alert |
08/10/2022 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $300.00M | — | — | Get Alert |
05/11/2022 | ADMA | ADMA Biologics | FY | 2025 | — | — | — | $300.00M | $300.00M | — | Get Alert |
05/11/2022 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $250.00M | $250.00M | — | Get Alert |
05/11/2022 | ADMA | ADMA Biologics | FY | 2022 | — | — | — | $130.00M | — | $128.50M | Get Alert |
03/24/2022 | ADMA | ADMA Biologics | FY | 2022 | — | — | — | $125.00M | — | $112.77M | Get Alert |
01/19/2022 | ADMA | ADMA Biologics | Q4 | 2021 | — | — | — | $26.00M | $26.00M | $21.76M | Get Alert |
01/19/2022 | ADMA | ADMA Biologics | FY | 2021 | — | — | — | $81.00M | $81.00M | $76.27M | Get Alert |
03/25/2021 | ADMA | ADMA Biologics | FY | 2024 | — | — | — | $250.00M | — | — | Get Alert |
01/19/2021 | ADMA | ADMA Biologics | Q4 | 2020 | — | — | — | $13.90M | $13.90M | $12.05M | Get Alert |
01/19/2021 | ADMA | ADMA Biologics | FY | 2020 | — | — | — | $42.20M | $42.20M | $40.33M | Get Alert |
01/09/2020 | ADMA | ADMA Biologics | FY | 2019 | — | — | — | $29.20M | $29.20M | $25.38M | Get Alert |
01/09/2020 | ADMA | ADMA Biologics | Q4 | 2019 | — | — | — | $11.90M | $11.90M | $8.64M | Get Alert |
There have been no specific sales or earnings guidance reported for ADMA Biologics in recent months.
Browse guidance and forecast on all stocks.